Multi-omics “upstream analysis” of regulatory genomic regions helps identifying targets against methotrexate resistance of colon cancer

Osborn, 1958, Inhibition of dihydrofolic reductase by aminopterin and amethopterin, Proc. Soc. Exp. Blot. Med., 97, 429, 10.3181/00379727-97-23764 Morales, 2005, Genetic determinants of methotrexate responsiveness and resistance in colon cancer cells, Oncogene, 24, 6842, 10.1038/sj.onc.1208834 De Anta, 2002, Unmasking the mechanisms of colon cancer cell resistance to methotrexate: cell drug sensitivity is dependent on a transiently adaptive mechanism, Gastroentérologie Clinique et Biologique, 26, 399 Fischer, 2015, Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance, Nature, 527, 472, 10.1038/nature15748 Kolesnikov, 2015, ArrayExpress update—simplifying data submissions, Nucleic Acids Res., 43, D1113, 10.1093/nar/gku1057 Barrett, 2013, NCBI GEO. archive for functional genomics data sets–update, Nucleic Acids Res., 41, D991, 10.1093/nar/gks1193 Petryszak, 2014, Expression atlas update—a database of gene and transcript expression from microarray- and sequencing-based functional genomics experiments, Nucleic Acids Res., 42, D926, 10.1093/nar/gkt1270 Smith, 2014, The mouse gene expression database (GXD): 2014 update, Nucleic Acids Res., 42, D818, 10.1093/nar/gkt954 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U. S. A., 102, 15545, 10.1073/pnas.0506580102 Kanehisa, 2012, KEGG for integration and interpretation of large-scale molecular data sets, Nucleic Acids Res., 40, D109, 10.1093/nar/gkr988 Kel, 2006, Beyond microarrays: find key transcription factors controlling signal transduction pathways, BMC Bioinf., 7, S13, 10.1186/1471-2105-7-S2-S13 Michael, 2008, Building a knowledge base for systems pathology, Brief. Bioinform., 9, 518, 10.1093/bib/bbn038 Stegmaier, 2011, Advanced computational biology methods identify molecular switches for malignancy in an EGF mouse model of liver cancer, PLoS One, 6, e17738, 10.1371/journal.pone.0017738 Wingender, 2008, The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation, Brief. Bioinform., 9, 326, 10.1093/bib/bbn016 Kel, 2003, MATCH: a tool for searching transcription factor binding sites in DNA sequences, Nucleic Acids Res., 31, 3576, 10.1093/nar/gkg585 Waleev, 2006, Composite module analyst: identification of transcription factor binding site combinations using genetic algorithm, Nucleic Acids Res., 34, W541, 10.1093/nar/gkl342 Krull, 2006, TRANSPATH: an information resource for storing and visualizing signaling pathways and their pathological aberrations, Nucleic Acids Res., 34, D546, 10.1093/nar/gkj107 Koschmann, 2015, Upstream analysis: an integrated promoter-pathway analysis approach to causal interpretation of microarray data, Microarrays, 4, 270, 10.3390/microarrays4020270 2010 Tropsha, 2010, QSAR in drug discovery, 151, 10.1017/CBO9780511730412.012 Filimonov, 1999, Chemical similarity assessment through multilevel neighborhoods of atoms: definition and comparison with the other descriptors, J. Chem. Inf. Comput. Sci, 39, 666, 10.1021/ci980335o Filimonov, 2008, 182 Demo workflows. Available online: http://www.genexplain.com/demo-workflows. Selga, 2008, Role of caveolin 1, E-cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells, BMC Med. Genomics, 1, 35, 10.1186/1755-8794-1-35 Smyth, 2005, Limma: linear models for microarray data, 397 McMahon, 2012, Characterization of changes in the proteome in different regions of 3D multicell tumor spheroids, J. Proteome Res., 11, 2863, 10.1021/pr2012472 Allen, 2015, The Mediator complex: a central integrator of transcription, Nat. Rev. Mol. Cell Biol., 16, 155, 10.1038/nrm3951 Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome, Genome Biol., 10, R25, 10.1186/gb-2009-10-3-r25 Zhang, 2008, Model-based analysis of chIP-Seq (MACS), Genome Biol., 9, R137, 10.1186/gb-2008-9-9-r137 Filimonov, 2008, 182 Stegmaier, 2011, Advanced computational biology methods identify molecular switches for malignancy in an EGF mouse model of liver cancer, PLoS One, 6, e17738, 10.1371/journal.pone.0017738 Viemann, 2004, Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cells, Blood, 103, 3365, 10.1182/blood-2003-09-3296 Schimke, 1978, Gene amplification and drug resistance in cultured murine cells, Science, 202, 1051, 10.1126/science.715457 Bertino, 1996, Resistance mechanisms to methotrexate in Tumors, Oncologist, 1, 223, 10.1634/theoncologist.1-4-223 Good, 1996, Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence, J. Cell. Physiol., 168, 580, 10.1002/(SICI)1097-4652(199609)168:3<580::AID-JCP10>3.0.CO;2-3 Lin, 1996, Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction, Mol. Cell. Biol., 16, 1668, 10.1128/MCB.16.4.1668 Kel-Margoulis, 2002, TRANSCompel: a database on composite regulatory elements in eukaryotic genes, Nucleic Acids Res., 30, 332, 10.1093/nar/30.1.332 Marra, 1998, Mismatch repair deficiency associated with overexpression of the MSH3 gene, Proc. Natl. Acad. Sci. U. S. A., 95, 8568, 10.1073/pnas.95.15.8568 Allen, 2015, The Mediator complex: a central integrator of transcription, Nat. Rev. Mol. Cell Biol., 16, 155, 10.1038/nrm3951 Firestein, 2008, CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity, Nature, 455, 547, 10.1038/nature07179 Zwang, 2012, Consistency test of the cell cycle: roles for p53 and EGR1, Cancer Res., 72, 1051, 10.1158/0008-5472.CAN-11-3382 El-Karim, 2013, Krüppel-like factor 4 regulates genetic stability in mouse embryonic fibroblasts, Mol. Cancer, 10.1186/1476-4598-12-89 Chen, 2002, Discordant protein and mrna expression in lung adenocarcinomas, Mol. Cell. Proteomics, 1, 304, 10.1074/mcp.M200008-MCP200 Goldhoff, 2008, Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression, Clin. Cancer Res., 14, 7717, 10.1158/1078-0432.CCR-08-0827 Valabrega, 2005, TGFalpha expression impairs trastuzumab-induced HER2 downregulation, Oncogene, 24, 3002, 10.1038/sj.onc.1208478 Mostovich, 2011, Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors, Cell Adh. Migr., 5, 395, 10.4161/cam.5.5.17949 Hatakeyama, 2009, Effect of insulin-like growth factor 1 receptor inhibitor on sensitization of head and neck cancer cells to cetuximab and methotrexate, J. Clin. Oncol., 10.1200/jco.2009.27.15_suppl.6079 Bug, 2005, Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia, Cancer, 104, 2717, 10.1002/cncr.21589 Coronel, 2011, A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results, Med. Oncol., 28, S540, 10.1007/s12032-010-9700-3 Munster, 2009, Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC, Clin. Cancer Res., 15, 2488, 10.1158/1078-0432.CCR-08-1930 Sun, 2014, Phosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition, PLoS One, 9, e90627, 10.1371/journal.pone.0090627 Moon, 2002, Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia, Clin. Cancer Res., 8, 589 Horsman, 1987, Radiosensitisation by nicotinamide in vivo: a greater enhancement of tumor damage compared to that of normal tissues, Radiat. Res., 109, 479, 10.2307/3577048 Kjellen, 1991, A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments, Radiother. Oncol., 22, 81, 10.1016/0167-8140(91)90002-X A. Kel, Master regulators and transcriptiption factor binding sites found by upstream analysis of multi-omics data on methotrexate resistance of colon cancer. Data in Brief. submitted.